Linaclotide
MCP-103-312
Approved small_molecule completed
Quick answer
Linaclotide for Irritable Bowel Syndrome Characterized by Constipation is a Approved program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IRONWOOD PHARMACEUTICALS INC
- Indication
- Irritable Bowel Syndrome Characterized by Constipation
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed